SeerPharma Pty Ltd :: DISCover web-based training :: Non-small Cell Lung Cancer: Treatment

Non-small Cell Lung Cancer: Treatment

Description: There has been a rapid increase in the incidence of lung cancer since the 1930s. The association between cigarette smoking and lung cancer was first proposed in 1941, and has been substantiated with epidemiological studies. Thus, as the numbers of cigarette-smoking individuals in a given population rises and falls, so do the rates of lung cancer. Lung cancer can be classified as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC), based on the characteristics of the disease and its response to treatment. This course describes the various treatment options and prognostic outcomes for the various stages and types of NSCLC.

COURSE OUTLINE

INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

PROGNOSIS
4. Objectives
5. Staging
6. Progress Check

TREATMENT
7. Objectives
8. Quality of Life Management
9. Surgery
10. Radiotherapy
11. Chemotherapy
12. Progress Check

CONCLUSION
13. Summary

COURSE OBJECTIVES

Students completing this course should be able to:

Explain how the TNM scale is used in grading lung cancers
Assign a stage to a particular TNM rating
Describe performance ratings and explain how they are used in treatment
List factors involved in making quality of life treatment decisions
Explain when and where surgery should be used
Describe the use of radiotherapy as both a palliative and curative tool
List the types of chemical agents used in chemotherapy

Home

Training Programs

Upcoming Training

Compliance Consulting

DISCover e-Learning

Modules available

SOPtrain

Quality Management Software

Clinical Trials Software

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.